Clinical Trial Update: A Study to Evaluate the Safety and Pharmacokinetics of BMS-986177 in Participants With End-stage Renal Dysfunction on Chronic Stable Hemodialysis Treatment [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the safety and pharmacokinetics of BMS-986177 in participants with end-stage renal dysfunction on chronic stable hemodialysis; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease
• Thrombosis

Drugs mentioned

• BMS-986177

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Thrombosis, Factor XI | Phase 1 | Status: COMPLETED